Combined Prospective and Retrospective Post-Market Follow Up of the 'BPK-S Integration' UC as Primary Implant in the Variant CoCr

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

October 17, 2018

Primary Completion Date

March 2, 2020

Study Completion Date

March 2, 2020

Conditions
Osteoarthritis, KneeJoint Instability
Interventions
DEVICE

BPK-S Integration

primary total knee endoprosthesis

Trial Locations (2)

7500

Centre Hospitalier de Wallonie picarde - CHwapi A.S.B.L, Tournai

Medical Center Tournai, Tournai

All Listed Sponsors
collaborator

P.R.I.S.M.A.-CRO

UNKNOWN

lead

Peter Brehm GmbH

INDUSTRY

NCT03406637 - Combined Prospective and Retrospective Post-Market Follow Up of the 'BPK-S Integration' UC as Primary Implant in the Variant CoCr | Biotech Hunter | Biotech Hunter